Relay Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Relay Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q1 2024.
  • Relay Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was -1.03K %, a 96.4% increase year-over-year.
  • Relay Therapeutics, Inc. annual Operating Margin for 2023 was -1.46K %, a 93.3% increase from 2022.
  • Relay Therapeutics, Inc. annual Operating Margin for 2022 was -21.7K %, a 80% decline from 2021.
  • Relay Therapeutics, Inc. annual Operating Margin for 2021 was -12K %, a 17736% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -1.03K +27.4K +96.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.46K +20.2K +93.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.37K +16K +92.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -38.9K -25.5K -191% Apr 1, 2023 Jun 30, 2023
Q1 2023 -28.4K -13K -84.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21.7K -9.63K -80% Oct 1, 2022 Dec 31, 2022
Q3 2022 -17.4K Jul 1, 2022 Sep 30, 2022
Q2 2022 -13.3K Apr 1, 2022 Jun 30, 2022
Q1 2022 -15.4K Jan 1, 2022 Mar 31, 2022
Q4 2021 -12K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.